Result Summary for EGF104535
| Protocol ID: | EGF104535 |
| Clinical Study ID: | EGF104535 |
| Official Title: | A Randomized, Multicenter, Double-Blind, Placebo-Controlled, Phase III Study of Lapatinib (GW572016) in Combination with Paclitaxel versus Paclitaxel plus Placebo in Subjects with ErbB2 Amplified Metastatic Breast Cancer |
| Phase: | phase 3 |
| Study Indications or Diseases: |
|
| Generic Name: | lapatinib |
| Trade/Product Name: | Tykerb,Tycerb,Tyverb |
| Approved Drug Label: | http://www.gsk.com/products.html |
| Results Summary: |  Click
here to download result summary. |
| Citations: |
|
The summaries are in PDF format. If you do not have Adobe® Acrobat® Reader™ installed, you can download it for free.
